Contacts
Contact email:Rita.Ferreira@anu.edu.au
Contact phone:+61 2 6125 0820
Location:Building 131 Garran Rd, Rm 3.366
PhD
Fellow
2016-2018 : Senior Scientist, Horizon Discovery, Cambridge, UK
2011-2016 : Senior Scientist, Neusentis, Pfizer, Cambridge, UK
2005-2011 : Research Associate (Postdoctoral Fellow), Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK
2004-2005 : Postdoctoral Fellow, Erasmus Medical Centre, Rotterdam, The Netherlands
1999-2004 : PhD in Cell Biology, Erasmus University, Rotterdam, The Netherlands
Groups
- Researcher, The Hannan Group - Cancer Therapeutics
- Collaborator, The Schulte Group - Systems Biology of Cancer
- Amarasiri, M, VO, Y, Gardiner, M et al. 2021, 'The Synthesis and Biological Evaluation of Some C-9 and C-10 Substituted Derivatives of the RNA Polymerase I Transcription Inhibitor CX-5461', Australian Journal of Chemistry, vol. 74, no. 7, pp. 540-556.
- Ferreira, R, Schneekloth Jr., J, Panov, K et al. 2020, 'Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age', Cells, vol. 9, no. 2.
- Franks, S, Firipis, K, Ferreira, R et al. 2020, 'Harnessing the self-assembly of peptides for the targeted delivery of anti-cancer agents', Materials Horizons, vol. 7, no. 8, pp. 1996-2010.
- Schwartzentruber, J, Foskolou, S, Kilpinen, H et al. 2018, 'Molecular and functional variation in iPSC-derived sensory neurons', Nature Genetics, vol. 50, no. 1, pp. 54-61.
- Skerratt, S, Humphreys, S, Ferreira, R et al. 2016, 'Identification of a novel BODIPY minihepcidin tool for the high content analysis of ferroportin (SLC40A1) pharmacology', RSC Medicinal Chemistry (Formerly MedChemComm), vol. 7, no. 8, pp. 1564-1571.
